NASDAQ
3.69USD
+0.23 (+6.65%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
284.8M
P/E
—
EPS
—
Beta
0.96
52W range
1.35-4.6
Day range
3.51–3.70
Open
3.51
Prev close
3.46
Volume
930.1K
Avg volume
1.3M
Dividend
0.00
IPO
2014-09-17
https://seekingalpha.com/article/4925846-eledon-at-the-center-of-the-next-medical-frontier · 7/27/2026+1.00
https://www.globenewswire.com/news-release/2026/04/20/3276901/0/en/NewcelX-Updates-Corporate-Presentation-to-Highlight-Type-1-Diabetes-Flagship-Program-Following-Strategic-Collaboration-with-Eledon-Pharmaceuticals-Ahead-of-Swiss-Biotech-Conference.html · 4/20/2026+0.60
https://www.globenewswire.com/news-release/2026/01/08/3215790/0/en/Eledon-Pharmaceuticals-Highlights-Recent-Business-Milestones-and-Provides-2026-Outlook.html · 1/8/2026+1.00
https://www.defenseworld.net/2025/12/20/analysts-set-eledon-pharmaceuticals-inc-nasdaqeldn-target-price-at-9-67.html · 12/20/2025+0.20
https://www.globenewswire.com/news-release/2025/09/24/3155831/0/en/Eledon-Pharmaceuticals-to-Present-at-the-18th-Congress-of-the-International-Xenotransplantation-Association.html · 9/24/2025+0.30
https://www.globenewswire.com/news-release/2025/08/14/3133904/0/en/Eledon-Pharmaceuticals-Reports-Second-Quarter-2025-Operating-and-Financial-Results.html · 8/14/2025+0.60
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
